GPhC should explain rise in premises fees, says PDA

Latest

GPhC should explain rise in premises fees, says PDA

Latest

 

The Pharmacists’ Defence Association (PDA) has urged the General Pharmaceutical Council (GPhC) to explain the rationale behind its proposed increased registration fee of £365 for pharmacy premises.

The regulator's official consultation on the premises fee hike closed at the end of March, during a time when many contractors have faced financial difficulties relating to the Covid-19 pandemic.

The fee for renewal and registration is set to go from £262 to £365, an increase the PDA said would give the GPhC £1.5 million in extra income.

The PDA said it supported “the principle of a fee increase” but insisted the regulator act “in line with the Nolan Principle of Openness” and present “a full and comprehensive set of financial workings on how it has arrived at the figure of £365.”

“The GPhC should not raise fees until it can detail and demonstrate independently verifiable efficiency gains on an annual basis before coming back to registrants for any increase in fees,” the PDA said.

It also said the GPhC should not expect “year on year increases in its income as a matter of right” and community pharmacy cannot support the “guarantee of a three-year fixed increase in fee income for the GPhC.”

The PDA added: “The GPhC must provide full working models on fees showing cost allocations according to registrant type.

“(It) must provide data if it is to introduce variable fees to show how the variances would impact different groups of registrants (pharmacists/technicians/premises).”

On accreditation MPharm courses, the PDA said fees must “properly be charged to institutions and not allocated as a cost when determining pharmacist registration fees.”

It also urged the GPhC to publish the equality impact analysis from the fees increase last year and in previous years.

When contacted by Independent Community Pharmacist, a GPhC spokesperson said: “We recognise that, at the current time, the first priority of pharmacy professionals and organisations is to focus on patient safety and dealing with the coronavirus outbreak. 

“We are carefully considering all responses to the consultation and will publish a summary of the responses, along with an explanation of the decision we have taken, in due course.”

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off

CCA & NPA update crisis guidance for second wave

Providing Pharmaceutical Care in Crisis Situations updates guidance first published in the spring.

1 Min Article

bookmark_icon_off

Pharmacy technician awarded £7k after new manager banned breaks

A pharmacy technician with scoliosis who was prevented from taking breaks during her shift has been awarded almost £7,000.

1 Min Article

bookmark_icon_off

Pharmacies dispensing 4x usual volume in COVID-19 crisis

Pharmacists in Northern Ireland have warned the public they are under huge pressure due to the COVID-19 crisis.

2 Min Article

bookmark_icon_off

Sale of 44 Boots stores 'exciting opportunity for independents'

Boots has put 44 of its pharmacies in England and Wales up for sale.

1 Min Article

bookmark_icon_off

New blister pack recycling scheme

Answering customers’ queries about recycling medicine blister packs just got easier, thanks to TerraCycle's new scheme.

2 Min Article

bookmark_icon_off

Minister thanks pharmacies but is silent on funding

Pharmacy minister Jo Churchill expressed her gratitude to community pharmacies for their work during the Covid-19 pandemic. 

 

2 Min Article

Recommended Learning

bookmark_icon_off

Skincare training for pharmacy

Delve into dry skin management and understand how you can make a difference to customers looking for advice, support and product recommendations to help manage their compromised skin.

30 Min Module

bookmark_icon_off

Treating acid reflux and heartburn in the pharmacy

Understand how omeprazole 20mg works to treat heartburn and acid reflux symptoms

4 Min Module

bookmark_icon_off

OTC Omeprazole tablets 20mg: an opportunity for pharmacy

This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.

22 Min Module

bookmark_icon_off

Female fertility

Improve your understanding of female fertility and consider the ways women can maximise their chances of conceiving.

10 Min Module

bookmark_icon_off

Travellers' diarrhoea

Improve your understanding on travellers' diarrhoea with this pharmacy scenario.

10 Min Module

bookmark_icon_off

Understanding the impact of dry skin conditions

Learn about the emotional impact of dry and eczema-prone skin, and confidently recommend products for skin treatment and maintenance.

15 Min Module